{"brand":"Compound Laws","url":"https://compoundlaws.com/compounds/4-ho-met/montana/","compound":{"slug":"4_ho_met","name":"4-HO-MET (Metocin)","same_as":"https://en.wikipedia.org/wiki/4-HO-MET"},"jurisdiction":{"code":"MT","name":"Montana"},"as_of":"2026-10-07","answer":"As of October 7, 2026, 4-HO-MET (Metocin) is legal to sell at retail with restrictions in Montana. Analog-exposed (Dangerous Drug Analogue). Controlling source: MCA Sec. 50-32-222 - Schedule I + analogue subsection (11).","forms":[{"form":"all","label":"All forms","status":"restricted","state_status":null,"federal_overlay":false,"headline":"Analog-exposed (Dangerous Drug Analogue)","rule_type":null,"tier":"analog_exposed","schedule_class":null,"limit":null,"effective_date":null,"verified_at":"2026-10-07","confidence":"confirmed","verbatim_excerpt":"**50-32-222(4) Hallucinogenic substances (header)** - \"Unless specifically excepted or listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following is a hallucinogenic substance, including salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:  (dd) psilocybin; (ee) psilocyn, also known as psilocin; \"\n- MCA 50-32-222(4), https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0220/0500-0320-0020-0220.html (official Montana Code Annotated 2025). 4-HO-MET (4-hydroxy-N-methyl-N-ethyltryptamine) does **not** appear anywhere in the enumerated list; the listed 4-/5-substituted tryptamines are bufotenine, 5-MeO-DIPT, 5-MeO-DMT, AMT, AET, DET, DMT - not 4-HO-MET.\n**50-32-222(5)(a)** - \"For the purposes of subsection (4), the term 'isomer' includes the optical, positional, and geometric isomers.\"\n- same URL (confirms the schedule's only catch-all reach is isomers, not homologs).\n**50-32-222(11) Dangerous drug analogues** - \"Unless specifically excepted or listed in another schedule, this designation includes any material, compound, mixture, or preparation defined in 50-32-101 as a dangerous drug analogue.\"\n- same URL.\n**50-32-101(7)(a)** - \"'Dangerous drug analogue' means any material, compound, mixture, or preparation that is structurally related to or chemically derived from any dangerous drug in Schedules I through V set forth in Title 50, chapter 32, part 2, or that is expressly or impliedly represented to produce or does produce a physiological effect similar to or greater than the effect of a dangerous drug in Schedules I through V.\"\n- MCA 50-32-101(7)(a), https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0010/section_0010/0500-0320-0010-0010.html (official MCA 2025).","excerpt_source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0220/0500-0320-0020-0220.html","citations":[{"title":"MCA Sec. 50-32-222 - Schedule I + analogue subsection (11)","url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0220/0500-0320-0020-0220.html","pinpoint":null,"publisher":"Montana Code Annotated 2025","type":"gov","primary":true,"official":true},{"title":"MCA Sec. 50-32-101(7) - Dangerous Drug Analogue definition","url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0010/section_0010/0500-0320-0010-0010.html","pinpoint":null,"publisher":"Montana Code Annotated 2025","type":"gov","primary":false,"official":true}],"history":[]}],"neighbors":[{"code":"ID","status":"legal"},{"code":"ND","status":"illegal"},{"code":"SD","status":"illegal"},{"code":"WY","status":"legal"}],"laws":[{"citation":"MCA 50-32-222(4) (Schedule I hallucinogens — enumerated, 4-HO-MET absent); MCA 50-32-222(11) + 50-32-101(7) (Dangerous Drug Analogue)","title":null,"official_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0220/0500-0320-0020-0220.html","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-06-19","text_hash":"2aaa76f87ec35feefabb3ab1b57986a40c597b4dd83b03fbe6afba996c638a42"},{"citation":"Mont. Code Ann. 50-32-222(11); 50-32-101(7)","title":"Dangerous drug analogues folded into Schedule I; dangerous drug analogue defined","official_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0220/0500-0320-0020-0220.html","source_label":"OFFICIAL","effective_date":null,"retrieved_date":"2026-07-20","text_hash":"e7b1283b843566508dac7cbb207e2437135ecc77359570c8187d4320afd3942b"}]}